Abstract:BACKGROUND: Insulin resistance, defined as a diminished ability to respond to the stimulation of insulin, is the main line for a variety of metabolic-related diseases. Punicalagin (PU), a hydrolyzable tannin of pomegranate juice, exhibits multiple biological properties, including anti-oxidant, anti-cancer and anti-inflammatory activities.OBJECTIVE: This research study aimed at determining the protective effect of PU on insulin resistance and to uncover the underlying mechanism based on the gut microbiota, IKKβ/NF-κB pathway, and autophagy.DESIGN: An insulin resistance animal model was established using C57BL/6 mice fed with a high-fat diet (HFD) for 8 weeks. The model included two groups continuing a HFD for 12 weeks with or without administering via gavage with PU 20 mg/kg/day. Changes in fasting plasma glucose levels, fasting serum insulin levels, glucose and insulin tolerance, glycolipid metabolism, gut microbiota composition (16S rRNA gene sequencing), inflammatory responses, and autophagy in the liver were evaluated. Body weight gain, glycolipid metabolic disorder, liver injury, as well as systemic and hepatic insulin sensitivity, were significantly attenuated after supplementing with PU.RESULTS: This research study revealed that PU alleviated HFD-induced glucose and lipid disorders, liver injury and insulin resistance; decreased the Firmicutes/Bacteroides ratio, decreased the abundance of Coprococcus and Anaerotruncus, and increased Rikenellaceae; and decreased serum and liver tumor necrosis factor-alpha and interleukin-1β levels, inhibited liver IKKβ and NF-κB phosphorylation; and increased liver autophagy-related proteins LC3-II, P62, and Beclin1, and increased the number of liver autophagosomes.CONCLUSION: PU can improve HFD-induced insulin resistance, improved liver glucose and lipid metabolism disorder and liver injury, and the potential mechanism is that PU inhibited the IKKβ/NF-κB inflammatory pathway by regulating gut microbiota homeostasis and up-regulating liver autophagy activity.

Protective mechanism of punicalagin against endoplasmic reticulum stress in the liver of mice with type 2 diabetes mellitus

Punicalagin Protects against Diabetic Liver Injury by Upregulating Mitophagy and Antioxidant Enzyme Activities

A New Possible Mechanism by Which Punicalagin Protects Against Liver Injury Induced by Type 2 Diabetes Mellitus: Upregulation of Autophagy Via the Akt/FoxO3a Signaling Pathway

Punicalagin Attenuates Neuronal Apoptosis by Upregulating 5-Hydroxymethylcytosine in the Diabetic Mouse Brain

Effect of punicalagin on multiple targets in streptozotocin/high-fat diet-induced diabetic mice

Punicalagin Alleviates Renal Injury Via the Gut-Kidney Axis in High-Fat Diet-Induced Diabetic Mice.

Punicalagin Improves Hepatic Lipid Metabolism Via Modulation Of Oxidative Stress And Mitochondrial Biogenesis In Hyperlipidemic Mice

A new way for punicalagin to alleviate insulin resistance: regulating gut microbiota and autophagy

Anti-diabetic Effect of Punica Granatum Flower Polyphenols Extract in Type 2 Diabetic Rats: Activation of Akt/GSK-3β and Inhibition of IRE1α-XBP1 Pathways

Punicalagin Protects Diabetic Nephropathy by Inhibiting Pyroptosis Based on TXNIP/NLRP3 Pathway

Punicalagin Protects Against Impaired Skeletal Muscle Function in High-Fat-diet-induced Obese Mice by Regulating TET2

Punica granatum L. peel extract protects diabetic nephropathy by activating the Nrf-2/HO-1 pathway

Punicalagin Attenuates Palmitate-Induced Lipotoxicity in HepG2 Cells by Activating the Keap1-Nrf2 Antioxidant Defense System.

Punicalagin Protects Against Diabetic Cardiomyopathy by Promoting Opa1-Mediated Mitochondrial Fusion via Regulating PTP1B-Stat3 Pathway

Punicalagin Prevents Hepatic Steatosis Through Improving Lipid Homeostasis and Inflammation in Liver and Adipose Tissue and Modulating Gut Microbiota in Western Diet-Fed Mice.

Punicalagin Ameliorates Diabetic Liver Injury by Inhibiting Pyroptosis and Promoting Autophagy via Modulation of the FoxO1/TXNIP Signaling Pathway

Mitochondrial Dysfunction in Obesity-Associated Nonalcoholic Fatty Liver Disease: the Protective Effects of Pomegranate with Its Active Component Punicalagin.

Punicalagin Relieves Lipotoxic Injuries on Pancreatic Β-Cells Via Regulating the Oxidative Stress and Endoplasmic Reticulum Stress-Mediated Apoptosis.

Punicalagin, an Active Component in Pomegranate, Ameliorates Cardiac Mitochondrial Impairment in Obese Rats Via AMPK Activation

Punicalagin Attenuates Endothelial Dysfunction by Activating FoxO1, a Pivotal Regulating Switch of Mitochondrial Biogenesis.

Punicalagin Reversed the Hepatic Injury of Tetrachloromethane by Antioxidation and Enhancement of Autophagy.